BRVE / USDNASDAQBraveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. The company is headquartered in San Francisco, California.




